作者
Sun-Hee Kim, Ellen C Henry, Dong-Kyu Kim, Yun-Hee Kim, Kum Joo Shin, Myoung Sook Han, Taehoon G Lee, Jong-Ku Kang, Thomas A Gasiewicz, Sung Ho Ryu, Pann-Ghill Suh
发表日期
2006/6/1
期刊
Molecular pharmacology
卷号
69
期号
6
页码范围
1871-1878
出版商
American Society for Pharmacology and Experimental Therapeutics
简介
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a widespread environmental pollutant with many toxic effects, including endocrine disruption, reproductive dysfunction, immunotoxicity, liver damage, and cancer. These are mediated by TCDD binding to and activating the aryl hydrocarbon receptor (AhR), a basic helix-loop-helix transcription factor. In this regard, targeting the AhR using novel small molecule inhibitors is an attractive strategy for the development of potential preventive agents. In this study, by screening a chemical library composed of approximately 10,000 compounds, we identified a novel compound, 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191), that potently inhibits TCDD-induced AhR-dependent transcription. In addition, CH-223191 blocked the binding of TCDD to AhR and inhibited TCDD-mediated nuclear translocation and DNA binding of AhR. These …
引用总数
2007200820092010201120122013201420152016201720182019202020212022202320243459142018271823172325272328248